We are live on ! Find out more
SRTA

Strata Critical Medical Inc

Fund managers haven’t disclosed any holdings of SRTA yet.

SRTA Hedge Fund Activity: Q1 2026 in Review

125 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc (SRTA) for Q1 2026, worth a combined $233M — down 6.8% from $250M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new SRTA positions and 17 closed out — a net gain of 3 holders — while 48 added to existing stakes and 36 trimmed.

The largest buyer was Northern Right Capital Management, adding an estimated $5.88M. The largest seller was Morgan Stanley, cutting an estimated $1.29M.

  • 125 institutional investors held Strata Critical Medical Inc (SRTA) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $233M of Strata Critical Medical Inc stock for Q1 2026, down 6.8% quarter-over-quarter.
  • 20 funds opened new Strata Critical Medical Inc positions in Q1 2026 and 17 closed out, a net change of +3 holders.
  • The largest Strata Critical Medical Inc buyer in Q1 2026 was Northern Right Capital Management, an estimated $5.88M added.
  • The largest Strata Critical Medical Inc seller in Q1 2026 was Morgan Stanley, an estimated $1.29M sold.

Based on aggregated 13F filings for Q1 2026.